1)Law RH, Caradoc-Davies T, Cowieson N, et al. The X-ray crystal structure of full-length human plasminogen. Cell Rep. 2012; 1(3): 185-90
|
|
|
2)Han J, Baik N, Kim KH, et al. Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen. Blood. 2011; 118(6): 1653-62
|
|
|
3)Shen Y, Guo Y, Mikus P, et al. Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds. Blood. 2012; 119(24): 5879-87
|
|
|
4)Godier A, Hunt BJ. Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease. J Thromb Haemost. 2013; 11(1): 26-34
|
|
|
5)Madureira PA, Surette AP, Phipps KD, et al. The role of the annexin A2 heterotetramer in vascular fibrinolysis. Blood. 2011; 118(18): 4789-97
|
|
|
6)Deora AB, Kreitzer G, Jacovina AT, et al. An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem. 2004; 279(42): 43411-8
|
|
|
7)Swisher JF, Khatri U, Feldman GM. Annexin A2 is a soluble mediator of macrophage activation. J Leukoc Biol. 2007; 82(5): 1174-84
|
|
|
8)Li Q, Ke F, Zhang W, et al. A role for the annexin A2 amino-terminal peptide in the plasmin-induced activation of human peripheral monocytes. Mol Immunol. 2010; 47(14): 2405-10
|
|
|
9)Madoiwa S, Someya T, Hironaka M, et al. Annexin 2 and hemorrhagic disorder in vascular intimal carcinomatosis. Thromb Res. 2007; 119(2): 229-40
|
|
|
10)Cesarman-Maus G, Rios-Luna NP, Deora AB, et al. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood. 2006; 107(11): 4375-82
|
|
|
11)Diaz-Ramos A, Roig-Borrellas A, Garcia-Melero A, et al. α-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol. 2012; 2012: 156795
|
|
|
12)Diaz-Ramos A, Roig-Borrellas A, Garcia-Melero A, et al. Requirement of plasminogen binding to its cell-surface receptor alpha-enolase for efficient regeneration of normal and dystrophic skeletal muscle. PLoS One. 2012; 7(12): e50477
|
|
|
13)Suelves M, Vidal B, Serrano AL, et al. uPA deficiency exacerbates muscular dystrophy in MDX mice. J Cell Biol. 2007; 178(6): 1039-51
|
|
|
14)Hsiao KC, Shih NY, Fang HL, et al. Surface α-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target. PLoS One. 2013; 8(7): e69354
|
|
|
15)Ghosh AK, Coppens I, Gardsvoll H, et al. Plasmodium ookinetes coopt mammalian plasminogen to invade the mosquito midgut. Proc Natl Acad Sci U S A. 2011; 108(41): 17153-8
|
|
|
16)Fulde M, Rohde M, Polok A, et al. Cooperative plasminogen recruitment to the surface of Streptococcus canis via M protein and enolase enhances bacterial survival. MBio. 2013; 4(2): e00629-12
|
|
|
17)Das R, Burke T, Van Wagoner DR, et al. L-type calcium channel blockers exert an antiinflammatory effect by suppressing expression of plasminogen receptors on macrophages. Circ Res. 2009; 105(2): 167-75
|
|
|
18)Das R and Plow EF. Phosphatidylserine as an anchor for plasminogen and its plasminogen receptor, histone H2B, to the macrophage surface. J Thromb Haemost. 2011; 9(2): 339-49
|
|
|
19)Miles LA, Lighvani S, Baik N, et al. The plasminogen receptor, Plg-R(KT), and macrophage function. J Biomed Biotechnol. 2012; 2012: 250464
|
|
|
20)Bai H, Baik N, Kiosses WB, et al. The novel plasminogen receptor, plasminogen receptor(KT) 〔Plg-R(KT)〕, regulates catecholamine release. J Biol Chem. 2011; 286(38): 33125-33
|
|
|
21)Gonzalez-Gronow M, Ray R, Wang F, et al. The voltage-dependent anion channel (VDAC) binds tissue-type plasminogen activator and promotes activation of plasminogen on the cell surface. J Biol Chem. 2013; 288(1): 498-509
|
|
|
22)Chen PK, Chang BI, Kuo CH, et al. Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. FASEB J 2013. DOI 10.1096/fj.13-227561
|
|
|
23)Suzuki Y, Yasui H, Brzoska T, et al. Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells. Blood. 2011; 118(11): 3182-5
|
|
|